These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 25163381)
1. Survival of Australian women with invasive epithelial ovarian cancer: a population-based study. Anuradha S; Webb PM; Blomfield P; Brand AH; Friedlander M; Leung Y; Obermair A; Oehler MK; Quinn M; Steer C; Jordan SJ Med J Aust; 2014 Sep; 201(5):283-8. PubMed ID: 25163381 [TBL] [Abstract][Full Text] [Related]
2. Variations in adjuvant chemotherapy and survival in women with epithelial ovarian cancer - a population-based study. Anuradha S; Donovan PJ; Webb PM; Brand AH; Goh J; Friedlander M; Oehler MK; Quinn M; Steer C; Jordan SJ Acta Oncol; 2016; 55(2):226-33. PubMed ID: 26079434 [TBL] [Abstract][Full Text] [Related]
3. The implications of age and comorbidity on survival following epithelial ovarian cancer: summary and results from a Centers for Disease Control and Prevention study. O'Malley CD; Shema SJ; Cress RD; Bauer K; Kahn AR; Schymura MJ; Wike JM; Stewart SL J Womens Health (Larchmt); 2012 Sep; 21(9):887-94. PubMed ID: 22816528 [TBL] [Abstract][Full Text] [Related]
4. Statin treatment is associated with survival in a nationally representative population of elderly women with epithelial ovarian cancer. Vogel TJ; Goodman MT; Li AJ; Jeon CY Gynecol Oncol; 2017 Aug; 146(2):340-345. PubMed ID: 28596017 [TBL] [Abstract][Full Text] [Related]
5. Associations between residual disease and survival in epithelial ovarian cancer by histologic type. Melamed A; Manning-Geist B; Bregar AJ; Diver EJ; Goodman A; Del Carmen MG; Schorge JO; Rauh-Hain JA Gynecol Oncol; 2017 Nov; 147(2):250-256. PubMed ID: 28822556 [TBL] [Abstract][Full Text] [Related]
6. Stages III and IV invasive epithelial ovarian carcinoma in younger versus older women: what prognostic factors are important? Chan JK; Loizzi V; Lin YG; Osann K; Brewster WR; DiSaia PJ Obstet Gynecol; 2003 Jul; 102(1):156-61. PubMed ID: 12850623 [TBL] [Abstract][Full Text] [Related]
7. Effects of access to and treatment in specialist facilities on survival from epithelial ovarian cancer in Australian women: a data linkage study. Tracey E; Hacker NF; Young J; Armstrong BK Int J Gynecol Cancer; 2014 Sep; 24(7):1232-40. PubMed ID: 25153678 [TBL] [Abstract][Full Text] [Related]
8. Ovarian cancer outcomes: Predictors of early death. Urban RR; He H; Alfonso R; Hardesty MM; Gray HJ; Goff BA Gynecol Oncol; 2016 Mar; 140(3):474-80. PubMed ID: 26743531 [TBL] [Abstract][Full Text] [Related]
9. Impact of Chemotherapy Dosing on Ovarian Cancer Survival According to Body Mass Index. Bandera EV; Lee VS; Rodriguez-Rodriguez L; Powell CB; Kushi LH JAMA Oncol; 2015 Sep; 1(6):737-45. PubMed ID: 26181758 [TBL] [Abstract][Full Text] [Related]
10. [Prognostic factors of epithelial ovarian cancer in young women]. Zhang R; Wu LY; Zhang WH; Li HJ; Li SM; Liu LY Zhonghua Zhong Liu Za Zhi; 2003 May; 25(3):264-7. PubMed ID: 12839691 [TBL] [Abstract][Full Text] [Related]
11. All-Cause Mortality After Fertility-Sparing Surgery for Stage I Epithelial Ovarian Cancer. Melamed A; Rizzo AE; Nitecki R; Gockley AA; Bregar AJ; Schorge JO; Del Carmen MG; Rauh-Hain JA Obstet Gynecol; 2017 Jul; 130(1):71-79. PubMed ID: 28594773 [TBL] [Abstract][Full Text] [Related]
12. Improved 5-year disease-free survival for FIGO stage I epithelial ovarian cancer patients without tumor rupture during surgery. Paulsen T; Kærn J; Tropé C Gynecol Oncol; 2011 Jul; 122(1):83-8. PubMed ID: 21435701 [TBL] [Abstract][Full Text] [Related]
13. Socioeconomic status and epithelial ovarian cancer survival in Sweden. Weiderpass E; Oh JK; Algeri S; Bellocco R Cancer Causes Control; 2014 Aug; 25(8):1063-73. PubMed ID: 24906473 [TBL] [Abstract][Full Text] [Related]
14. Incidence, mortality, and survival trends of ovarian cancer in Hong Kong, 1997 to 2006: a population-based study. Wong KH; Mang OW; Au KH; Law SC Hong Kong Med J; 2012 Dec; 18(6):466-74. PubMed ID: 23223646 [TBL] [Abstract][Full Text] [Related]
15. Pre-diagnosis diet and survival after a diagnosis of ovarian cancer. Playdon MC; Nagle CM; Ibiebele TI; Ferrucci LM; Protani MM; Carter J; Hyde SE; Neesham D; Nicklin JL; Mayne ST; Webb PM Br J Cancer; 2017 Jun; 116(12):1627-1637. PubMed ID: 28463959 [TBL] [Abstract][Full Text] [Related]
17. Oral Contraceptive Use and Reproductive Characteristics Affect Survival in Patients With Epithelial Ovarian Cancer: A Cohort Study. Kolomeyevskaya NV; Szender JB; Zirpoli G; Minlikeeva A; Friel G; Cannioto RA; Brightwell RM; Grzankowski KS; Moysich KB Int J Gynecol Cancer; 2015 Nov; 25(9):1587-92. PubMed ID: 26273932 [TBL] [Abstract][Full Text] [Related]
18. Lymph node metastases as only qualifier for stage IV serous ovarian cancer confers longer survival than other sites of distant disease - a Swedish Gynecologic Cancer Group (SweGCG) study. Hjerpe E; Staf C; Dahm-Kähler P; Stålberg K; Bjurberg M; Holmberg E; Borgfeldt C; Tholander B; Hellman K; Kjølhede P; Högberg T; Rosenberg P; Åvall-Lundqvist E Acta Oncol; 2018 Mar; 57(3):331-337. PubMed ID: 29130381 [TBL] [Abstract][Full Text] [Related]
19. Patterns of chemotherapy treatment for women with invasive epithelial ovarian cancer--a population-based study. Jordan S; Steer C; DeFazio A; Quinn M; Obermair A; Friedlander M; Francis J; O'Brien S; Goss G; Wyld D; Australian Ovarian Cancer Study Group ; Webb P; Gynecol Oncol; 2013 May; 129(2):310-7. PubMed ID: 23403164 [TBL] [Abstract][Full Text] [Related]
20. Prognostic value of tissue protein expression levels of MIB-1 (Ki-67) in Danish ovarian cancer patients. From the 'MALOVA' ovarian cancer study. Heeran MC; Høgdall CK; Kjaer SK; Christensen L; Jensen A; Blaakaer J; Christensen IJ; Høgdall EV APMIS; 2013 Dec; 121(12):1177-86. PubMed ID: 23594232 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]